跳至主要内容
临床试验/NCT01308047
NCT01308047撤回3 期

Comparative Study of Non-inferiority Between Heavy Levobupivacaine With Enantiomeric Excess of 50% (Bupivacaine S75: R25) and Heavy Racemic Bupivacaine (Bupivacaine S50: R50) in Spinal Anesthesia for Orthopedic Procedures in the Lower Limbs.

Cristália Produtos Químicos Farmacêuticos Ltda.2 个研究点 分布在 1 个国家开始时间: 2011年3月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
试验地点
2
主要终点
Time of latency for sensory block at T10 dermatome.

研究概览

简要总结

The purpose of this study is to compare the non-inferiority between Heavy Levobupivacaine with Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine During Spinal Anesthesia for Orthopedic Procedures in the Lower Limbs.

详细描述

The Heavy Levobupivacaine with Enantiomeric Excess of 50% was developed to be a safe local anesthetic replacing the Heavy Racemic Bupivacaine.

This study will evaluate the non-inferiority regarding efficacy and safety of spinal anesthesia in orthopedic procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA (American Society of Anesthesiologists) I or ASA II
  • Spinal Anaesthesia for lower limb surgery
  • Patient Consent

排除标准

  • relative or absolute contraindications for spinal anesthesia
  • history of hypersensitivity to the local anesthetics or components
  • opioids for anesthetic adjuvant
  • spinal lesions, peripheral neuropathies or any other neurologic disorders that leads to changes of sensitivity
  • Body mass index = or > 35
  • lumbar puncture difficulty
  • ventricular extrasystoles
  • dementia, others loss of cognitive ability
  • difficulty in the spine
  • spinal cord surgery
  • anaphylactic reactions or Stevens-johnson Syndrome
  • polytraumatism
  • alcoholism abuse and use of illicit substance
  • Changes in the blood test
  • Others conditions judged by investigator's opinion

研究组 & 干预措施

bupivacaine S75:R25

Experimental

3 ml for subarachnoid block

干预措施: Bupivacaine (Drug)

bupivacaine (S50:R50)

Active Comparator

3 ml subarachnoid block

干预措施: Bupivacaine (Drug)

结局指标

主要结局

Time of latency for sensory block at T10 dermatome.

时间窗: +/- 40 min after injection

Evaluate the sensory block at T10 after the anesthetic injection through sensory stimulation by needle.

次要结局

  • Motor Block Evaluation(+/- 30 min)
  • Maximum cranial dispersion verifying the largest metamer achieved.(+/- 45 min)
  • Time of regression of motor block by Bromage Scale(+/- 9 - 10 hours)
  • Evaluation of the cardiocirculatory and respiratory parameters(+/- 8 hours)
  • Sensory block duration(+/- 3 hours)
  • The residual analgesic effect(+/- 9-10 hours)
  • Anesthetic failure(+/- 45 min)
  • Adverse Events(+/- 8 - 12 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验